关注
Xiancai Ma
Xiancai Ma
其他姓名Xian-Cai Ma
Guangzhou Laboratory
在 gzlab.ac.cn 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Y Zhang, Y Chen, Y Li, F Huang, B Luo, Y Yuan, B Xia, X Ma, T Yang, ...
Proceedings of the National Academy of Sciences 118 (23), e2024202118, 2021
4072021
Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses
X Ma, F Zou, F Yu, R Li, Y Yuan, Y Zhang, X Zhang, J Deng, T Chen, ...
Immunity 53 (6), 1315-1330. e9, 2020
2592020
Teicoplanin potently blocks the cell entry of 2019-nCoV
J Zhang, X Ma, F Yu, J Liu, F Zou, T Pan, H Zhang
biorxiv 2020, 2.05. 935387, 2020
1752020
Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation
J Li, C Chen, X Ma, G Geng, B Liu, Y Zhang, S Zhang, F Zhong, C Liu, ...
Nature communications 7 (1), 11730, 2016
1662016
Structure of Schlafen13 reveals a new class of tRNA/rRNA-targeting RNase engaged in translational control
JY Yang, XY Deng, YS Li, XC Ma, JX Feng, B Yu, Y Chen, YL Luo, ...
Nature communications 9 (1), 1165, 2018
1102018
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
X Ma, T Yang, Y Luo, L Wu, Y Jiang, Z Song, T Pan, B Liu, G Liu, J Liu, ...
Elife 8, e42426, 2019
872019
HIV-1 functional cure: will the dream come true?
C Liu, X Ma, B Liu, C Chen, H Zhang
BMC medicine 13, 1-12, 2015
802015
Infection of wild-type mice by SARS-CoV-2 B. 1.351 variant indicates a possible novel cross-species transmission route
T Pan, R Chen, X He, Y Yuan, X Deng, R Li, H Yan, S Yan, J Liu, Y Zhang, ...
Signal transduction and targeted therapy 6 (1), 420, 2021
642021
Nonsteroidal anti-inflammatory drugs potently inhibit the replication of Zika viruses by inducing the degradation of AXL
T Pan, Z Peng, L Tan, F Zou, N Zhou, B Liu, L Liang, C Chen, J Liu, L Wu, ...
Journal of virology 92 (20), 10.1128/jvi. 01018-18, 2018
582018
Differential efficiencies to neutralize the novel mutants B. 1.1. 7 and 501Y. V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus …
R Li, X Ma, J Deng, Q Chen, W Liu, Z Peng, Y Qiao, Y Lin, X He, H Zhang
Cellular & molecular immunology 18 (4), 1058-1060, 2021
322021
Non-coding RNAs and retroviruses
X Zhang, X Ma, S Jing, H Zhang, Y Zhang
Retrovirology 15, 1-14, 2018
312018
Development of an attenuated tat protein as a highly-effective agent to specifically activate HIV-1 latency
G Geng, B Liu, C Chen, K Wu, J Liu, Y Zhang, T Pan, J Li, Y Yin, J Zhang, ...
Molecular Therapy 24 (9), 1528-1537, 2016
302016
Histone chaperone CAF‐1 promotes HIV‐1 latency by leading the formation of phase‐separated suppressive nuclear bodies
X Ma, T Chen, Z Peng, Z Wang, J Liu, T Yang, L Wu, G Liu, M Zhou, ...
The EMBO Journal 40 (10), e106632, 2021
252021
Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing
G Liu, X Ma, Z Wang, K Wakae, Y Yuan, Z He, H Yoshiyama, H Iizasa, ...
Journal of Biological Chemistry 294 (38), 14043-14054, 2019
232019
USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication
T Pan, Z Song, L Wu, G Liu, X Ma, Z Peng, M Zhou, L Liang, B Liu, J Liu, ...
Elife 8, e48318, 2019
222019
CUL7 E3 ubiquitin ligase mediates the degradation of activation-induced cytidine deaminase and regulates the Ig class switch recombination in B lymphocytes
Y Luo, Y Liu, L Wu, X Ma, Q Liu, F Huang, X Zhang, Y Zhang, J Zhang, ...
The Journal of Immunology 203 (1), 269-281, 2019
212019
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
Y Yuan, X Zhang, R Chen, Y Li, B Wu, R Li, F Zou, X Ma, X Wang, Q Chen, ...
Cell Reports 38 (3), 2022
202022
Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L
F Yu, T Pan, F Huang, R Ying, J Liu, H Fan, J Zhang, W Liu, Y Lin, Y Yuan, ...
Frontiers in Microbiology 13, 884034, 2022
182022
Lovastatin inhibits HIV-1-induced MHC-I downregulation by targeting Nef–AP-1 complex formation: A new strategy to boost immune eradication of HIV-1 infected cells
B Liu, X Zhang, W Zhang, L Wu, S Jing, W Liu, B Xia, F Zou, L Lu, X Ma, ...
Frontiers in Immunology 10, 2151, 2019
162019
CBX4 contributes to HIV‐1 latency by forming phase‐separated nuclear bodies and SUMOylating EZH2
L Wu, T Pan, M Zhou, T Chen, S Wu, X Lv, J Liu, F Yu, Y Guan, B Liu, ...
EMBO reports 23 (7), e53855, 2022
142022
系统目前无法执行此操作,请稍后再试。
文章 1–20